Abstract
Female C57BL/6 mice aged 6-8 weeks with transplanted Lewis lung cancer cells were used to investigate the anti-tumour effects and immune reactions in tumour tissue induced by X-ray and pion irradiation and their modification by schizophyllan (SPG). The effect of SPG on the rate of lung metastasis and the survival time of the mice was also studied using the same tumour system. These studies showed that in this tumour system the "practical' relative biological effectiveness (RBE) of pions was 1.33 in the dose ranges used (3 Gy x 4 = P3; 6 Gy x 4 = P6). SPG increased the suppression of tumour growth associated with moderate doses of radiation: X-rays (4 Gy x 4 = X4) or P3. SPG also decreased the number of lung metastases and prolonged the life span of the mice, these effects being independent of radiation. The addition of SPG to radiation increased both the macrophage infiltration and T-lymphocyte infiltration in the local tumour and the lung nodules. There did not appear to be any major differential effect of SPG on the pion-treated mice compared with those treated with X-rays.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chaplin D. J., Douglas B. G., Grulkey W., Skarsgard L. D., Lam G., Denekamp J. The response of mouse epidermis to fractionated doses of pi mesons. Int J Radiat Oncol Biol Phys. 1987 Aug;13(8):1199–1208. doi: 10.1016/0360-3016(87)90195-7. [DOI] [PubMed] [Google Scholar]
- Chaplin D. J., Douglas B. G., Saito T., Skarsgard L. D., Lam G. K., Denekamp J. Preclinical evaluation of pions in vivo: experience at TRIUMF. Radiother Oncol. 1990 Jan;17(1):7–15. doi: 10.1016/0167-8140(90)90043-v. [DOI] [PubMed] [Google Scholar]
- Douglas B. G., Fowler J. F. The effect of multiple small doses of x rays on skin reactions in the mouse and a basic interpretation. Radiat Res. 1976 May;66(2):401–426. [PubMed] [Google Scholar]
- Ogawa Y., Goodman G. B., Chaplin D. J., Grulkey W., Lam G. K. Combination therapy of pions and SPG (Sonifilan, Schizophyllan), a biological response modifier for mouse tumor systems. Int J Radiat Oncol Biol Phys. 1990 Jun;18(6):1415–1420. doi: 10.1016/0360-3016(90)90316-c. [DOI] [PubMed] [Google Scholar]
- Ogawa Y., Maeda T., Seguchi H., Yoshida S., Inomata T., Hamada F., Kishimoto S., Saito H., Osaki T. Immunohistochemical study of mononuclear cell infiltrates in squamous cell carcinoma of oral cavity and paranasal sinus. Oncology. 1987;44(4):219–223. doi: 10.1159/000226481. [DOI] [PubMed] [Google Scholar]
- Skarsgard L. D., Palcic B., Douglas B. G., Lam G. K. Radiobiology of pions at TRIUMF. Int J Radiat Oncol Biol Phys. 1982 Dec;8(12):2127–2132. doi: 10.1016/0360-3016(82)90556-9. [DOI] [PubMed] [Google Scholar]
- Sugawara I., Lee K. C., Wong M. Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells. I. Characteristics of SPG-treated macrophages. Cancer Immunol Immunother. 1984;16(3):137–144. doi: 10.1007/BF00205419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yamamoto T., Yamashita T., Tsubura E. Inhibition of pulmonary metastasis of Lewis lung carcinoma by a glucan, Schizophyllan. Invasion Metastasis. 1981;1(1):71–84. [PubMed] [Google Scholar]